AESCULATECH INC

Los Angeles, CA · Medtech · Private

Patient-adaptable punctal plug made from environmentally sensitive hydrogels with reverse phase transition behavior

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Headquarters
Los Angeles, CA
Total capital
$1.7M
Federal grants
$1.7M
3 awards · 2023–2025
Rank in peer group#239 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
10 pending · first 2022
Rank in peer group#106 of 542

Capital timeline

202320242025FEDERAL ↑EQUITY ↓Cumulative $1.7M$250K$250K$1.2M
202320242025FEDERAL ↑EQUITY ↓Cumulative $1.7M$250K$250K$1.2M

Latest events

  • Federal grantHealth and Human S · Phase II · Humidifeye Plug for Dry Eye Disease$1.2M
  • Federal grantHealth and Human S · Phase I · Humidifeye Plug for Dry Eye Disease$250K
  • Federal grantHealth and Human S · Phase II · Humidifeye Plug for Dry Eye Disease$250K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#239 · top 44%
  • Granted patents#106 · top 20%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

No founders are linked to this company yet.

Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.

Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026

Claim this profile to add your team

What it has protected

USPTO · 1 granted of 11
  • PendingDevice for Controlled Injection Across a Variety of Material PropertiesUSPTOApplication 19343408
  • PendingMulti-component Responsive Copolymers And Applications ThereofUSPTOApplication 18746505
  • PendingHydrogels Composed Of Binary Copolymers And Applications ThereofUSPTOApplication 19240222
Show all 11 patent records
  • Device for Controlled Injection Across a Variety of Material PropertiesJan 29, 2026 · Application 19343408Pending
  • Multi-component Responsive Copolymers And Applications ThereofDec 18, 2025 · Application 18746505Pending
  • Hydrogels Composed Of Binary Copolymers And Applications ThereofDec 18, 2025 · Application 19240222Pending
  • Coating Compositions And Applications ThereofSep 26, 2024 · Application 18610507Pending
  • Thermoresponsive Polymers And Uses ThereofOct 20, 2022 · Application 17808855Pending
  • Thermoresponsive Polymers And Uses ThereofAug 2, 2022 · US 11,400,044Granted
  • Thermoresponsive Polymers And Uses ThereofApplication 62521188Pending
  • Hydrogels Composed Of Binary Copolymers And Applications ThereofApplication 63661185Pending
  • Coating Compositions And Applications ThereofApplication 63453669Pending
  • Device For Controlled Injection Across A Variety Of Material PropertiesApplication 63101228Pending
  • Thermoresponsive Polymers And Uses ThereofApplication PCTUS2018037899Pending

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .